Physician-Modified Fenestrated and Branched Aortic Endografting for TAAA
NCT: NCT02989948 · RECRUITING
Brief Summary
The primary clinical objective of this study is to evaluate the safety and effectiveness of a physician-modified, fenestrated and branched aortic endoprosthesis for the treatment of thoracoabdominal aortic aneurysms (TAAAs). The goal of the primary analysis is to demonstrate both the safety and effectiveness of using a physician-modified fenestrated Cook Zenith Alpha Thoracic Endovascular Graft as compared to previously published results of open surgical replacement of the aneurysmal aorta.
Frequently Asked Questions
What is Physician-Modified Fenestrated and Branched Aortic Endografting for TAAA?
Physician-Modified Fenestrated and Branched Aortic Endografting for TAAA is a clinical trial registered under NCT02989948. Current status: RECRUITING.
What is the status of NCT02989948?
The current status of NCT02989948 (Physician-Modified Fenestrated and Branched Aortic Endografting for TAAA) is: RECRUITING.
When did Physician-Modified Fenestrated and Branched Aortic Endografting for TAAA start?
Physician-Modified Fenestrated and Branched Aortic Endografting for TAAA started on 2020-04-22.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.